Technical Analysis for PETX - Aratana Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 4.75 -3.26% -0.16
PETX closed down 3.26 percent on Friday, January 19, 2018, on 1.31 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
3 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical PETX trend table...

Date Alert Name Type % Chg
Jan 19 MACD Bearish Signal Line Cross Bearish 0.00%
Jan 19 New 52 Week Closing Low Bearish 0.00%
Jan 19 Lower Bollinger Band Walk Weakness 0.00%
Jan 19 New 52 Week Low Weakness 0.00%
Jan 19 Stochastic Reached Oversold Weakness 0.00%
Jan 19 Wide Bands Range Expansion 0.00%
Jan 19 Below Lower BB Weakness 0.00%
Jan 19 Down 3 Days in a Row Weakness 0.00%
Jan 19 Down 4 Days in a Row Weakness 0.00%
Jan 19 Down 5 Days in a Row Weakness 0.00%

Older signals for PETX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Is PETX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.12
52 Week Low 4.67
Average Volume 590,097
200-Day Moving Average 6.1394
50-Day Moving Average 5.828
20-Day Moving Average 5.2115
10-Day Moving Average 5.083
Average True Range 0.2572
ADX 39.29
+DI 11.33
-DI 38.4
Chandelier Exit (Long, 3 ATRs ) 4.9584
Chandelier Exit (Short, 3 ATRs ) 5.4416
Upper Bollinger Band 5.5633
Lower Bollinger Band 4.8597
Percent B (%b) -0.16
BandWidth 13.500911
MACD Line -0.2153
MACD Signal Line -0.2023
MACD Histogram -0.013
Fundamentals Value
Market Cap 204.26 Million
Num Shares 43 Million
EPS -1.61
Price-to-Earnings (P/E) Ratio -2.95
Price-to-Sales 26.68
Price-to-Book 2.44
PEG Ratio -0.35
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.13
Resistance 3 (R3) 5.14 5.03 5.06
Resistance 2 (R2) 5.03 4.93 5.02 5.04
Resistance 1 (R1) 4.89 4.88 4.84 4.88 5.02
Pivot Point 4.78 4.78 4.75 4.77 4.78
Support 1 (S1) 4.64 4.68 4.59 4.63 4.48
Support 2 (S2) 4.53 4.63 4.52 4.46
Support 3 (S3) 4.39 4.53 4.44
Support 4 (S4) 4.38